5-amino-1mq human studies safety 5-Amino-1MQ Peptide Therapy (Promote Fat

This dose was chosen based on a previous dose-escalation study and subsequent work demonstrating its efficacy to drive weight loss in a short period of time 8

Research has demonstrated that peptide-based therapies can effectively reduce inflammation and alleviate symptoms in patients with chronic conditions

While individual responses vary, some patients report fewer or different side effects compared to injectable weight loss medications

Figure 3)

Selective fat targeting: Some evidence suggests AOD 9604 preferentially targets visceral fat (the dangerous fat around your organs) over subcutaneous fat (under your skin)